Cwm, LLC Amicus Therapeutics, Inc. Transaction History
Cwm, LLC
- $21.2 Billion
- Q2 2024
A detailed history of Cwm, LLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Cwm, LLC holds 1,443 shares of FOLD stock, worth $16,868. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,443
Previous 1,752
17.64%
Holding current value
$16,868
Previous $21,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding FOLD
# of Institutions
279Shares Held
324MCall Options Held
260KPut Options Held
261K-
Vanguard Group Inc Valley Forge, PA28.6MShares$334 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY28.1MShares$328 Million8.05% of portfolio
-
Avoro Capital Advisors LLC New York, NY27.4MShares$320 Million3.71% of portfolio
-
Black Rock Inc. New York, NY24.4MShares$285 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA21.1MShares$247 Million0.04% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $3.28B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...